Skip to main content
Sadhana Nitrochem Ltd. logo

Sadhana Nitrochem Ltd. — Investor Relations & Filings

Ticker · SADHNANIQ ISIN · INE888C01040 BSE.NS Manufacturing
Open in API
Filings indexed 837 across all filing types
Latest filing 2024-02-01 Regulatory Filings
Country IN India
Listing BSE.NS SADHNANIQ

About Sadhana Nitrochem Ltd.

https://www.sncl.com

Sadhana Nitrochem Ltd. specializes in the manufacture of chemical intermediates and performance chemicals. The company's core product portfolio includes nitrobenzene and its downstream derivatives such as metanilic acid, aniline 2,5 disulphonic acid, and sodium meta nitrobenzene sulphonate. These products serve as critical raw materials for the global dyes, pigments, pharmaceuticals, and agrochemicals sectors. The company operates advanced manufacturing facilities focused on high-purity chemical synthesis and process optimization. Its technical capabilities extend to specialized chemical reactions including nitration, hydrogenation, and sulfonation. By maintaining a vertically integrated production model, the company ensures consistent quality and supply chain reliability for its international client base across various industrial applications.

Recent filings

Filing Released Lang Actions
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a communication addressed to stock exchanges (BSE Limited and National Stock Exchange of India) regarding the newspaper publication of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2023. It references compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which mandates the publication of financial results in newspapers. The document includes excerpts of financial data such as total income, net profit, and earnings per share for the quarter and nine months ended December 31, 2023, and mentions that these results were approved by the Board of Directors. The document is essentially an announcement of the publication of quarterly financial results in newspapers, not the full detailed financial report itself. It is a regulatory filing informing the exchanges and public about the publication of the financial results. Therefore, it fits best under the category of Regulatory Filings (RNS), as it is a general regulatory announcement and does not contain the full financial statements or detailed analysis required for an Interim/Quarterly Report (IR).
2024-02-01 English
Pursuant to Regulation 47 of SEBI (LODR) Regulation, 2015, Please find enclosed herewith the copies of newspaper publication of Unaudited Standalone and Consolidate Financial Results of ....
Regulatory Filings Classification · 95% confidence The document is a communication addressed to stock exchanges (BSE Limited and National Stock Exchange of India) regarding the newspaper publication of unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2023. It references Regulation 47 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015, which mandates the publication of financial results in newspapers. The document includes excerpts of unaudited financial results, mentions approval by the Board of Directors, and provides summary financial data for the quarter and nine months ended December 31, 2023. The document is not the full financial report but a notice of the publication of financial results in newspapers, which is a regulatory disclosure. It does not contain comprehensive financial statements or detailed analysis typical of an Interim/Quarterly Report (IR) but rather a summary extract published in newspapers as per regulatory requirements. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement of financial results publication, not the full interim report itself.
2024-02-01 English
Change in Director(s)
Regulatory Filings
2024-01-30 English
Pursuant to regulation 30 of SEBI (LODR) Regulation, 2015, the Board of Directors of the company, at its meeting held today, i.e. Tuesday, January 30, 2024 has inter-alia considered and ....
Regulatory Filings
2024-01-30 English
Outcome of Board Meeting
Regulatory Filings
2024-01-30 English
Pursuant to regulation 30 and 33 of SEBI (LODR) Regulation, 2015, the Board of Directors of the Company, at its meeting held today i.e. Tuesday, January 30, 2024 has inter-alia: 1. Considered, ....
Regulatory Filings
2024-01-30 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.